Clinical applications of proteomics.

J Nutr

U. S. Food and Drug Administration-National Cancer Institute Clinical Proteomics Program, Center for Biologic Evaluation and Research, U. S. Food and Drug Administration, Rockville, MD 20852, USA.

Published: July 2003

Proteomics, the systematic evaluation of changes in the protein constituency of a cell, is more than just the generation of lists of proteins that increase or decrease in expression as a cause or consequence of disease. The ultimate goal is to characterize the information flow through protein pathways that interconnect the extracellular microenvironment with the control of gene transcription. The nature of this information can be a cause or a consequence of disease processes. Clinical applications of proteomics involve the use of proteomic technologies at the bedside. The analysis of human cancer as a model for how proteomics can have an impact at the bedside is now employing several new proteomic technologies that are being developed for early detection, therapeutic targeting and finally, patient-tailored therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jn/133.7.2476SDOI Listing

Publication Analysis

Top Keywords

clinical applications
8
applications proteomics
8
consequence disease
8
proteomic technologies
8
proteomics
4
proteomics proteomics
4
proteomics systematic
4
systematic evaluation
4
evaluation changes
4
changes protein
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!